- Home
- Publications
- Publication Search
- Publication Details
Title
Metastatic pathways in patients with cutaneous melanoma
Authors
Keywords
-
Journal
Pigment Cell & Melanoma Research
Volume 30, Issue 1, Pages 13-27
Publisher
Wiley
Online
2016-10-20
DOI
10.1111/pcmr.12544
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Identification of a Circulating MicroRNA Profile as a Biomarker of Metastatic Cutaneous Melanoma
- (2016) V Armand-Labit et al. ACTA DERMATO-VENEREOLOGICA
- Prognostic implications of epithelial to mesenchymal transition related proteins (E-cadherin, Snail) and hypoxia inducible factor 1α in endometrioid endometrial carcinoma
- (2016) Nehal S. Abouhashem et al. Annals of Diagnostic Pathology
- Meta-analysis of downregulated E-cadherin as a poor prognostic biomarker for cervical cancer
- (2016) Jifeng Peng et al. Future Oncology
- BRAF and epithelial-mesenchymal transition in primary cutaneous melanoma: a role for Snail and E-cadherin?
- (2016) Brendon Mitchell et al. HUMAN PATHOLOGY
- Identification, Review, and Systematic Cross-Validation of microRNA Prognostic Signatures in Metastatic Melanoma
- (2016) Kaushala Jayawardana et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Quantitative assessment of BRAF V600 mutant circulating cell-free tumor DNA as a tool for therapeutic monitoring in metastatic melanoma patients treated with BRAF/MEK inhibitors
- (2016) Max Schreuer et al. Journal of Translational Medicine
- Melanoma miRNA trafficking controls tumour primary niche formation
- (2016) Shani Dror et al. NATURE CELL BIOLOGY
- Clinical and biological determinants of melanoma progression: Should all be considered for clinical management?
- (2015) Casey J Rowe et al. AUSTRALASIAN JOURNAL OF DERMATOLOGY
- The role ofBRAFmutations in primary melanoma growth rate and survival
- (2015) V.J. Mar et al. BRITISH JOURNAL OF DERMATOLOGY
- Circulating Melanoma Cell Subpopulations: Their Heterogeneity and Differential Responses to Treatment
- (2015) Elin S. Gray et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Sensitivity of plasma BRAFmutant and NRASmutant cell-free DNA assays to detect metastatic melanoma in patients with low RECIST scores and non-RECIST disease progression
- (2015) Gregory A. Chang et al. Molecular Oncology
- The biology of circulating tumor cells
- (2015) K Pantel et al. ONCOGENE
- Circulating Tumor Cells, DNA, and mRNA: Potential for Clinical Utility in Patients With Melanoma
- (2015) M. J. Xu et al. ONCOLOGIST
- MicroRNAs in melanocyte and melanoma biology
- (2015) Marina Mione et al. Pigment Cell & Melanoma Research
- MicroRNA and mRNA expression profiling in metastatic melanoma reveal associations withBRAFmutation and patient prognosis
- (2015) Varsha Tembe et al. Pigment Cell & Melanoma Research
- Comparison of a healthy miRNome with melanoma patient miRNomes: are microRNAs suitable serum biomarkers for cancer?
- (2015) Christiane Margue et al. Oncotarget
- Monitoring response to therapy in melanoma by quantifying circulating tumour DNA with droplet digital PCR for BRAF and NRAS mutations
- (2015) Simon Chang-Hao Tsao et al. Scientific Reports
- BRAF and NRAS Mutations are Heterogeneous and Not Mutually Exclusive in Nodular Melanoma
- (2015) Caterina Chiappetta et al. APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY
- Association BetweenNRASandBRAFMutational Status and Melanoma-Specific Survival Among Patients With Higher-Risk Primary Melanoma
- (2015) Nancy E. Thomas et al. JAMA Oncology
- The Prognostic and Predictive Value of Melanoma-related MicroRNAs Using Tissue and Serum: A MicroRNA Expression Analysis
- (2015) Mitchell S. Stark et al. EBioMedicine
- Phenotype Switching in Melanoma: Implications for Progression and Therapy
- (2015) Frederic Zhentao Li et al. Frontiers in Oncology
- Evaluating biomarkers in melanoma
- (2015) Panagiotis Karagiannis et al. Frontiers in Oncology
- Micrometastatic cancer cells in lymph nodes, bone marrow, and blood: Clinical significance and biologic implications
- (2014) Stanley P.L. Leong et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Serum-based miRNAs in the prediction and detection of recurrence in melanoma patients
- (2014) Nathaniel H. Fleming et al. CANCER
- BRAF mutation status is an independent prognostic factor for resected stage IIIB and IIIC melanoma: Implications for melanoma staging and adjuvant therapy
- (2014) Andrew P. Barbour et al. EUROPEAN JOURNAL OF CANCER
- Immunohistochemical analysis of molecular drivers in melanoma identifies p16 as an independent prognostic biomarker
- (2014) Johanne Lade-Keller et al. JOURNAL OF CLINICAL PATHOLOGY
- Prognostic value of BRAF mutations in localized cutaneous melanoma
- (2014) Eduardo Nagore et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Safety and efficacy of vemurafenib in BRAFV600E and BRAFV600K mutation-positive melanoma (BRIM-3): extended follow-up of a phase 3, randomised, open-label study
- (2014) Grant A McArthur et al. LANCET ONCOLOGY
- Ultraviolet-radiation-induced inflammation promotes angiotropism and metastasis in melanoma
- (2014) Tobias Bald et al. NATURE
- Final Trial Report of Sentinel-Node Biopsy versus Nodal Observation in Melanoma
- (2014) Donald L. Morton et al. NEW ENGLAND JOURNAL OF MEDICINE
- Combined BRAF and MEK Inhibition versus BRAF Inhibition Alone in Melanoma
- (2014) Georgina V. Long et al. NEW ENGLAND JOURNAL OF MEDICINE
- Clinical and pathological associations of the activatingRAC1P29S mutation in primary cutaneous melanoma
- (2014) Victoria J. Mar et al. Pigment Cell & Melanoma Research
- Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
- (2014) C. Bettegowda et al. Science Translational Medicine
- Blood-Based Analyses of Cancer: Circulating Tumor Cells and Circulating Tumor DNA
- (2014) D. A. Haber et al. Cancer Discovery
- Circulating tumor DNA analysis as a real-time method for monitoring tumor burden in melanoma patients undergoing treatment with immune checkpoint blockade
- (2014) Evan J Lipson et al. Journal for ImmunoTherapy of Cancer
- Melanoma Cells Revive an Embryonic Transcriptional Network to Dictate Phenotypic Heterogeneity
- (2014) Niels Vandamme et al. Frontiers in Oncology
- The clinical significance ofBRAFandNRASmutations in a clinic-based metastatic melanoma cohort
- (2013) H. Ekedahl et al. BRITISH JOURNAL OF DERMATOLOGY
- Emerging trends in the epidemiology of melanoma
- (2013) V. Nikolaou et al. BRITISH JOURNAL OF DERMATOLOGY
- A Switch in the Expression of Embryonic EMT-Inducers Drives the Development of Malignant Melanoma
- (2013) Julie Caramel et al. CANCER CELL
- Circulating miRNAs as sensitive and specific biomarkers for the diagnosis and monitoring of human diseases: Promises and challenges
- (2013) V. De Guire et al. CLINICAL BIOCHEMISTRY
- BRAF/NRAS Wild-Type Melanomas Have a High Mutation Load Correlating with Histologic and Molecular Signatures of UV Damage
- (2013) V. J. Mar et al. CLINICAL CANCER RESEARCH
- Detection rate and prognostic value of circulating tumor cells and circulating tumor DNA in metastatic uveal melanoma
- (2013) François-Clément Bidard et al. INTERNATIONAL JOURNAL OF CANCER
- Detecting Circulating Tumor Cells: Current Challenges and New Trends
- (2013) Bin Hong et al. Theranostics
- Prognostic Value of BRAF V600 Mutations in Melanoma Patients After Resection of Metastatic Lymph Nodes
- (2012) Stéphanie Moreau et al. ANNALS OF SURGICAL ONCOLOGY
- Serum markers lactate dehydrogenase and S100B predict independently disease outcome in melanoma patients with distant metastasis
- (2012) B Weide et al. BRITISH JOURNAL OF CANCER
- Markers of circulating tumour cells in the peripheral blood of patients with melanoma correlate with disease recurrence and progression
- (2012) A.L. Reid et al. BRITISH JOURNAL OF DERMATOLOGY
- A Landscape of Driver Mutations in Melanoma
- (2012) Eran Hodis et al. CELL
- Distinguishing Clinicopathologic Features of Patients with V600E and V600K BRAF-Mutant Metastatic Melanoma
- (2012) A. M. Menzies et al. CLINICAL CANCER RESEARCH
- BRAF/NRASMutation Frequencies Among Primary Tumors and Metastases in Patients With Melanoma
- (2012) Maria Colombino et al. JOURNAL OF CLINICAL ONCOLOGY
- BRAF Mutation, NRAS Mutation, and the Absence of an Immune-Related Expressed Gene Profile Predict Poor Outcome in Patients with Stage III Melanoma
- (2012) Graham J. Mann et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Oncogenic B-RAFV600E Signaling Induces the T-Box3 Transcriptional Repressor to Repress E-Cadherin and Enhance Melanoma Cell Invasion
- (2012) Suzanah C. Boyd et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Biomarker Utility of Circulating Tumor Cells in Metastatic Cutaneous Melanoma
- (2012) Leila Khoja et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Serum microRNAs as biomarkers for recurrence in melanoma
- (2012) Erica B Friedman et al. Journal of Translational Medicine
- Dabrafenib in BRAF-mutated metastatic melanoma: a multicentre, open-label, phase 3 randomised controlled trial
- (2012) Axel Hauschild et al. LANCET
- The prognostic impact of the anatomical sites in the ‘head and neck melanoma’
- (2012) Vincenzo de Giorgi et al. MELANOMA RESEARCH
- Exome sequencing identifies recurrent somatic RAC1 mutations in melanoma
- (2012) Michael Krauthammer et al. NATURE GENETICS
- Survival in BRAF V600–Mutant Advanced Melanoma Treated with Vemurafenib
- (2012) Jeffrey A. Sosman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Time Course and Pattern of Metastasis of Cutaneous Melanoma Differ between Men and Women
- (2012) Liljana Mervic PLoS One
- Small RNAs have a large impact
- (2012) Matthew Weiland et al. RNA Biology
- NRAS mutation status is an independent prognostic factor in metastatic melanoma
- (2011) John A. Jakob et al. CANCER
- Tumor Metastasis: Molecular Insights and Evolving Paradigms
- (2011) Scott Valastyan et al. CELL
- Prevalence of BRAF V600E mutation in Chinese melanoma patients: Large scale analysis of BRAF and NRAS mutations in a 432-case cohort
- (2011) Lu Si et al. EUROPEAN JOURNAL OF CANCER
- Prognostic and Clinicopathologic Associations of OncogenicBRAFin Metastatic Melanoma
- (2011) Georgina V. Long et al. JOURNAL OF CLINICAL ONCOLOGY
- Melanoma survival in the United States, 1992 to 2005
- (2011) Lori A. Pollack et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- p16 Expression: A marker of differentiation between childhood malignant melanomas and Spitz nevi
- (2011) Rola Al Dhaybi et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
- (2011) Paul B. Chapman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Clinical outcome and pathological features associated with NRAS mutation in cutaneous melanoma
- (2011) Bianca Devitt et al. Pigment Cell & Melanoma Research
- Immunohistochemical Evaluation of p16INK4A, E-Cadherin, and Cyclin D1 Expression in Melanoma and Spitz Tumors
- (2010) Evan George et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- Serial Monitoring of Circulating Tumor Cells Predicts Outcome of Induction Biochemotherapy plus Maintenance Biotherapy for Metastatic Melanoma
- (2010) K. Koyanagi et al. CLINICAL CANCER RESEARCH
- A new understanding in the epidemiology of melanoma
- (2010) Esther Erdei et al. Expert Review of Anticancer Therapy
- Gender Differences in Melanoma Survival: Female Patients Have a Decreased Risk of Metastasis
- (2010) Arjen Joosse et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
- (2010) F. Stephen Hodi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dissection of RAS downstream pathways in melanomagenesis: a role for Ral in transformation
- (2010) P J Mishra et al. ONCOGENE
- Genetic and morphologic features for melanoma classification
- (2010) Sigrid M. C. Broekaert et al. Pigment Cell & Melanoma Research
- S-100B Concentrations Predict Disease-Free Survival in Stage III Melanoma Patients
- (2009) S. Kruijff et al. ANNALS OF SURGICAL ONCOLOGY
- The basics of epithelial-mesenchymal transition
- (2009) Raghu Kalluri et al. JOURNAL OF CLINICAL INVESTIGATION
- Final Version of 2009 AJCC Melanoma Staging and Classification
- (2009) Charles M. Balch et al. JOURNAL OF CLINICAL ONCOLOGY
- p16 Expression differentiates between desmoplastic Spitz nevus and desmoplastic melanoma
- (2009) Nicholaus J. Hilliard et al. JOURNAL OF CUTANEOUS PATHOLOGY
- Tissue Biomarkers for Prognosis in Cutaneous Melanoma: A Systematic Review and Meta-analysis
- (2009) Bonnie E. Gould Rothberg et al. JNCI-Journal of the National Cancer Institute
- Angiotropism is an Independent Predictor of Local Recurrence and In-transit Metastasis in Primary Cutaneous Melanoma
- (2008) Simone L. Van Es et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Survival Differences Between Patients With Scalp or Neck Melanoma and Those With Melanoma of Other Sites in the Surveillance, Epidemiology, and End Results (SEER) Program
- (2008) Anne M. Lachiewicz et al. ARCHIVES OF DERMATOLOGY
- Geographical variation of incidence of cutaneous melanoma in Queensland
- (2008) Petra Gertraud Buettner et al. Australian Journal of Rural Health
- Age and gender are significant independent predictors of survival in primary cutaneous melanoma
- (2008) Konstantinos Lasithiotakis et al. CANCER
- Induction of EMT by Twist Proteins as a Collateral Effect of Tumor-Promoting Inactivation of Premature Senescence
- (2008) Stéphane Ansieau et al. CANCER CELL
- Prognostic Significance of Cadherin-Based Adhesion Molecules in Cutaneous Malignant Melanoma
- (2008) G. M. Kreizenbeck et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- In vivo Switching of Human Melanoma Cells between Proliferative and Invasive States
- (2008) K. S. Hoek et al. CANCER RESEARCH
- Melanoma epidemiology and trends
- (2008) Claus Garbe et al. CLINICS IN DERMATOLOGY
- Prognostic Significance of Serum S100B Protein in High-Risk Surgically Resected Melanoma Patients Participating in Intergroup Trial ECOG 1694
- (2008) Ahmad A. Tarhini et al. JOURNAL OF CLINICAL ONCOLOGY
- Long-Term Survival Analysis in Metastatic Melanoma: Serum S100B Is an Independent Prognostic Marker and Superior to LDH
- (2008) Friederike Egberts et al. ONKOLOGIE
- Circulating microRNAs as stable blood-based markers for cancer detection
- (2008) P. S. Mitchell et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Improving Melanoma Classification by Integrating Genetic and Morphologic Features
- (2008) Amaya Viros et al. PLOS MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started